To elevate serotonin activity beyond the first-line serotonin reuptake inhibitor antidepressant effect, to treat depression patients responding inadequately, has been pursued from the 1970s (11, 28) till the present (29, 54) , by adjunctive (add-on) administration of a compound inducing Serotonin Synthesis Amplification: The optimal active compound to use in pharmaceutical technologies designed to produce Serotonin Synthesis Amplification is 5-hydroxytryptophan, 5-HTP
The care and communication has been second to none
It has no therapeutic pharmacokinetic profile in this context because it is used only as a preservative/diluent at 0.9%
For some people, pursuing weight loss can be harmful, for instance by leading to weight cycling or increasing the risk of developing an eating disorder
Which boosts energy more, NAD+ or B12 injections
GLP-1 agonists, known to be beneficial in treating type 2 diabetes, are glucagon-like peptide-1 receptor agonists